Desjardins Global Asset Management’s Quest Diagnostics DGX Stock Holding History

Desjardins Global Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$769K	Buy	5,577 +59	+1%	+$7.76K	0.08%	201
2023 Q3	$672K	Buy	5,518 +1,988	+56%	+$265K	0.07%	224
2023 Q2	$496K	Buy	3,530 +573	+19%	+$79K	0.06%	289
2023 Q1	$418K	Sell	2,957 -447	-13%	-$64K	0.05%	280
2022 Q4	$532K	Buy	3,404 +143	+4%	+$20.5K	0.08%	209
2022 Q3	$400K	Sell	3,261 -103	-3%	-$13.6K	0.05%	251
2022 Q2	$447K	Sell	3,364 -120	-3%	-$16.4K	0.06%	240
2022 Q1	$476K	Sell	3,484 -88	-2%	-$12.3K	0.04%	270
2021 Q4	$617K	Buy	+3,572	New	+$544K	0.05%	256

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Desjardins Global Asset Management's DGX Position: Q4 2023 in Review

Desjardins Global Asset Management increased its Quest Diagnostics (DGX) stake by 1.1% in Q4 2023, buying an estimated $7.76K and bringing the position to 5,577 shares worth $769K. The position accounts for 0.08% of the portfolio, ranked #201.

Desjardins Global Asset Management first reported a position in DGX in Q4 2021 and has held it in 9 quarters since. 826 funds tracked by Wall St. Rank hold DGX as of Q4 2023.

Desjardins Global Asset Management held 5,577 shares of Quest Diagnostics worth $769K as of Q4 2023.
Desjardins Global Asset Management bought 59 Quest Diagnostics shares in Q4 2023, an estimated $7.76K.
Quest Diagnostics made up 0.08% of Desjardins Global Asset Management's portfolio in Q4 2023, its #201 holding.
Desjardins Global Asset Management first reported a position in Quest Diagnostics in Q4 2021 and has held it in 9 quarters since.
826 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.